CR20160116A - Método para tratar onicomicosis con hidroxipropil quitasano - Google Patents

Método para tratar onicomicosis con hidroxipropil quitasano

Info

Publication number
CR20160116A
CR20160116A CR20160116A CR20160116A CR20160116A CR 20160116 A CR20160116 A CR 20160116A CR 20160116 A CR20160116 A CR 20160116A CR 20160116 A CR20160116 A CR 20160116A CR 20160116 A CR20160116 A CR 20160116A
Authority
CR
Costa Rica
Prior art keywords
quitasan
onycomycosis
hydroxipropil
treat
hydroxypropyl chitosan
Prior art date
Application number
CR20160116A
Other languages
English (en)
Inventor
Federico Mailland
Maurizio Caserini
Daniela Ceriani
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49118439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20160116(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of CR20160116A publication Critical patent/CR20160116A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

La presente invención está dirigida a un método para el tratamiento de onicomicosis mediante la administración tópica de una composición que contiene hidroxipropil quitosano como único ingrediente activo y, en particular, mediante la administración de una composición tópica para las uñas que consiste esencialmente en:a) hidroxipropil quitosano,b) agua,c) al menos un alcanol inferior.
CR20160116A 2013-09-10 2016-03-07 Método para tratar onicomicosis con hidroxipropil quitasano CR20160116A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13183789.0A EP2845597A1 (en) 2013-09-10 2013-09-10 Hydroxypropyl chitosan for the treatment of onychomycosis
PCT/EP2014/069099 WO2015036369A1 (en) 2013-09-10 2014-09-08 Method to treat onychomycosis by hydroxypropyl chitosan

Publications (1)

Publication Number Publication Date
CR20160116A true CR20160116A (es) 2016-06-14

Family

ID=49118439

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160116A CR20160116A (es) 2013-09-10 2016-03-07 Método para tratar onicomicosis con hidroxipropil quitasano

Country Status (20)

Country Link
US (1) US20160213705A1 (es)
EP (2) EP2845597A1 (es)
JP (1) JP2016529326A (es)
KR (1) KR20160051751A (es)
CN (1) CN105579047A (es)
AU (1) AU2014320473A1 (es)
CA (1) CA2922236A1 (es)
CL (1) CL2016000542A1 (es)
CR (1) CR20160116A (es)
EA (1) EA201690551A1 (es)
HK (1) HK1223042A1 (es)
IL (1) IL244423A0 (es)
MA (1) MA38896A1 (es)
MD (1) MD20160039A2 (es)
MX (1) MX2016003122A (es)
PE (1) PE20160530A1 (es)
PH (1) PH12016500471A1 (es)
SG (1) SG11201601200SA (es)
TN (1) TN2016000054A1 (es)
WO (1) WO2015036369A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate

Also Published As

Publication number Publication date
CN105579047A (zh) 2016-05-11
MD20160039A2 (ro) 2016-07-31
WO2015036369A1 (en) 2015-03-19
EA201690551A1 (ru) 2016-07-29
TN2016000054A1 (en) 2017-07-05
EP2845597A1 (en) 2015-03-11
CL2016000542A1 (es) 2016-10-07
PE20160530A1 (es) 2016-05-21
MA38896A1 (fr) 2018-03-30
SG11201601200SA (en) 2016-03-30
CA2922236A1 (en) 2015-03-19
PH12016500471A1 (en) 2016-05-16
IL244423A0 (en) 2016-04-21
AU2014320473A1 (en) 2016-03-24
JP2016529326A (ja) 2016-09-23
US20160213705A1 (en) 2016-07-28
EP3043804A1 (en) 2016-07-20
MX2016003122A (es) 2016-11-14
KR20160051751A (ko) 2016-05-11
HK1223042A1 (zh) 2017-07-21

Similar Documents

Publication Publication Date Title
CO2018001375A2 (es) Composiciones de retinoides tópicos
CO6821938A2 (es) Un compuesto de guanidina o una sal del mismo para el tratamiento de enfermedades relacionadas con vap -1
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
NI201700135A (es) Derivados de ciclohexano sustituido con amido
ECSP15030799A (es) Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y métodos de tratamiento con los mismos
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
GT201400003A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CO7131352A2 (es) Composiciones farmacéuticas tópicas
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
DOP2016000007A (es) Pirazolpiridinas sustituidas
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
ECSP15033898A (es) Composición antifúngica tópica para el tratamiento de onicomicosis
NI201500007A (es) Formulación transdérmica que contiene inhibidores de cox
UY35695A (es) Composicion para el tratamiento contra el envejecimiento de la piel
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
CR20160116A (es) Método para tratar onicomicosis con hidroxipropil quitasano
NI201200196A (es) Agentes terapéuticos 976
AR092169A1 (es) Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararla
CR20150328A (es) Agente de control de plagas
CL2010001230A1 (es) Metodo para inhibir la melanogenesis que comprende administrar un compuesto esteroidal; composicin farmaceutica; formulacion topica, util en el tratamiento de una enfermedad o condicion que involucra melanogenesis.